Diagnosticos da America revenue and financials
R$4.37Change from previous close: +6.85%Absolute change: +R$0.28
In the fiscal year ended December 2025, Diagnosticos da America reported revenue of R$11.17B (−27.10% year over year). The net loss was R$1.15B.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −27.10%
- 2025 vs 2024
- Net margin
- -10.3%
- 2024: -7.8%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 11,170 | 15,322 | 14,252 | 13,129 | 10,419 |
| Cost of revenue | 7,777 | 11,129 | 10,365 | 9,330 | 7,302 |
| Gross profit | 3,393 | 4,193 | 3,887 | 3,798 | 3,117 |
| Selling, general and administrative | 2,381 | 3,187 | 2,975 | 2,864 | 3,066 |
| Operating income | 1,009 | 1,094 | 913 | 1,017 | 88.5 |
| EBIT | 1,009 | 1,094 | 913 | 1,017 | 88.5 |
| EBITDA | 1,499 | 1,751 | 2,210 | 2,128 | 1,018 |
| Interest expense | 1,528 | 1,689 | 2,206 | 1,678 | 669 |
| Pre-tax income | -613 | -1,067 | -996 | -579 | -374 |
| Income tax | 522 | 129 | 134 | -191 | -157 |
| Net income | -1,152 | -1,199 | -1,166 | -387 | -227 |
| Net income to common shareholders | -1,152 | -1,199 | -1,166 | -387 | -227 |
| Basic EPS | -0.92 | -0.96 | -1.56 | -0.69 | -0.39 |
| Diluted EPS | -0.92 | -0.96 | -1.56 | -0.69 | -0.39 |
| Average shares (basic) | 1,255 | 1,250 | 747 | 558 | 585 |
| Average shares (diluted) | 1,255 | 1,250 | 747 | 558 | 585 |
| Dividend per share | — | — | — | — | 0.30 |